Table 5.
Biomarkers | Reference number | Case controls studies | Biomarkers of brain atrophy and rate of cognitive decline | Biomarkers of brain amyloid burden | Biomarkers of CSF Aβ |
clusterin | 6 | [36] | [33], [45], [41], [43], [44] | [41] | |
complement C3 | 6 | [45], [41], [48], [59] | [56], [58], [59] | ||
FGG | 5 | [41], [48] | [57], [59] | [79] | |
APOE | 4 | [36] | [44] | [59], [56] | |
PPY | 3 | [33], [59] | [59], [71] | ||
α2M | 3 | [15] | [57], [58] | ||
α-1-antitrypsin | 3 | [45] | [45], [44], [59] | [59] | |
FCN2 | 3 | [33] | [79], Baird et al., | ||
unpublished | |||||
TTR | 3 | [41], [44], [49] |
α2M, α-2-macroglobulin; FGG, γ-fibrinogen; PPY, pancreatic polypeptide; FCN2, ficolin-2; TTR, transthyretin.